Search
Research
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.
Smoking + BMI in heart disease
WGS for cardiovascular outcomes
RNA-Seq in pancreatic cancer
A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
Request Access
Overview
Selected Publications (2)
Variables (13)
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
M. Davids, Haesook T. Kim, P. Bachireddy, et al. (2016). The New England journal of medicine. Cited 334 times.
https://doi.org/10.1056/NEJMoa1601202
A multicenter, phase I study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
M. Davids, Haesook T. Kim, C. Costello, et al. (2020). Blood. Cited 63 times.
https://doi.org/10.1182/blood.2019004710
